Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1991 Nov;50(Suppl 4):846–853. doi: 10.1136/ard.50.suppl_4.846

Epidemiology of scleroderma.

A J Silman 1
PMCID: PMC1033319  PMID: 1750796

Full text

PDF
846

Images in this article

847Image
on p.847

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aeschlimann A., de Truchis P., Kahn M. F. Scleroderma after therapy with appetite suppressants. Report on four cases. Scand J Rheumatol. 1990;19(1):87–90. doi: 10.3109/03009749009092627. [DOI] [PubMed] [Google Scholar]
  2. Alarcón G. S., McCarty G. A., Lanyon P., Phillips R. M., Acton R. T., Barger B. O. Scleroderma: DR antigens, autoantibodies and clinical manifestations. Clin Exp Rheumatol. 1987 Oct-Dec;5(4):317–321. [PubMed] [Google Scholar]
  3. Alonso-Ruiz A., Zea-Mendoza A. C., Salazar-Vallinas J. M., Rocamora-Ripoll A., Beltrán-Gutiérrez J. Toxic oil syndrome: a syndrome with features overlapping those of various forms of scleroderma. Semin Arthritis Rheum. 1986 Feb;15(3):200–212. doi: 10.1016/0049-0172(86)90017-x. [DOI] [PubMed] [Google Scholar]
  4. Ansell B. M., Nasseh G. A., Bywaters E. G. Scleroderma in childhood. Ann Rheum Dis. 1976 Jun;35(3):189–197. doi: 10.1136/ard.35.3.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ballou S. P., Morley J. J., Kushner I. Pregnancy and systemic sclerosis. Arthritis Rheum. 1984 Mar;27(3):295–298. doi: 10.1002/art.1780270308. [DOI] [PubMed] [Google Scholar]
  6. Barnett A. J., Miller M. H., Littlejohn G. O. A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple cutaneous classification in the early stages of the disease. J Rheumatol. 1988 Feb;15(2):276–283. [PubMed] [Google Scholar]
  7. Barnett A. J. Scleroderma (progressive systemic sclerosis): progress and course based on a personal series of 118 cases. Med J Aust. 1978 Aug 12;2(4):129–134. doi: 10.5694/j.1326-5377.1978.tb131413.x. [DOI] [PubMed] [Google Scholar]
  8. Barnett A. J., Tait B. D., Barnett M. A., Toh B. H. T lymphocyte subset abnormalities and HLA antigens in scleroderma (systemic sclerosis). Clin Exp Immunol. 1989 Apr;76(1):24–29. [PMC free article] [PubMed] [Google Scholar]
  9. Bernstein R., Prinsloo I., Zwi S., Andrew M. J., Dawson B., Jenkins T. Chromosomal aberrations in occupation-associated progressive systemic sclerosis. S Afr Med J. 1980 Aug 9;58(6):235–237. [PubMed] [Google Scholar]
  10. Birnbaum N. S., Rodnan G. P., Rabin B. S., Bassion S. Histocompatibility antigens in progressive systemic sclerosis (scleroderma). J Rheumatol. 1977 Winter;4(4):425–428. [PubMed] [Google Scholar]
  11. Black C. M., Welsh K. I., Maddison P. J., Jayson M. I., Bernstein R. M. HLA antigens, autoantibodies and clinical subsets in scleroderma. Br J Rheumatol. 1984 Nov;23(4):267–271. doi: 10.1093/rheumatology/23.4.267. [DOI] [PubMed] [Google Scholar]
  12. Black C. M., Welsh K. I., Walker A. E., Bernstein R. M., Catoggio L. J., McGregor A. R., Jones J. K. Genetic susceptibility to scleroderma-like syndrome induced by vinyl chloride. Lancet. 1983 Jan 1;1(8314-5):53–55. doi: 10.1016/s0140-6736(83)91578-7. [DOI] [PubMed] [Google Scholar]
  13. Bosmanský K., Zitnan D., Urbánek T., Svec V. Výskyt difúznych chorôb spojiva s osobitým zretel'om na systémový lupus erythematosus na vybranom území v rokoch 1961-1969. Fysiatr Revmatol Vestn. 1971 Dec;49(6):267–272. [PubMed] [Google Scholar]
  14. Briggs D. C., Welsh K., Pereira R. S., Black C. M. A strong association between null alleles at the C4A locus in the major histocompatibility complex and systemic sclerosis. Arthritis Rheum. 1986 Oct;29(10):1274–1277. doi: 10.1002/art.1780291014. [DOI] [PubMed] [Google Scholar]
  15. Burge K. M., Perry H. O., Stickler G. B. "Familial" scleroderma. Arch Dermatol. 1969 Jun;99(6):681–687. [PubMed] [Google Scholar]
  16. Burge S. M., Ryan T. J., Dawber R. P. Juvenile onset systemic sclerosis. J R Soc Med. 1984 Sep;77(9):793–794. doi: 10.1177/014107688407700916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Christy W. C., Rodnan G. P. Conjugal progressive systemic sclerosis (scleroderma): report of the disease in husband and wife. Arthritis Rheum. 1984 Oct;27(10):1180–1182. doi: 10.1002/art.1780271015. [DOI] [PubMed] [Google Scholar]
  18. Cowie R. L. Silica-dust-exposed mine workers with scleroderma (systemic sclerosis). Chest. 1987 Aug;92(2):260–262. doi: 10.1378/chest.92.2.260. [DOI] [PubMed] [Google Scholar]
  19. Czirják L., Dankó K., Schlammadinger J., Surányi P., Tamási L., Szegedi G. Y. Progressive systemic sclerosis occurring in patients exposed to chemicals. Int J Dermatol. 1987 Jul-Aug;26(6):374–378. doi: 10.1111/j.1365-4362.1987.tb00565.x. [DOI] [PubMed] [Google Scholar]
  20. Dalziel J. A., Wilcock G. K. Progressive systemic sclerosis in the elderly. Postgrad Med J. 1979 Mar;55(641):192–193. doi: 10.1136/pgmj.55.641.192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Dustoor M. M., McInerney M. M., Mazanec D. J., Cathcart M. K. Abnormal lymphocyte function in scleroderma: a study on identical twins. Clin Immunol Immunopathol. 1987 Jul;44(1):20–30. doi: 10.1016/0090-1229(87)90048-1. [DOI] [PubMed] [Google Scholar]
  22. ERASMUS L. D. Scleroderma in goldminers on the Witwatersrand with particular reference to pulmonary manifestations. S Afr J Lab Clin Med. 1957 Sep;3(3):209–231. [PubMed] [Google Scholar]
  23. Eason R. J., Tan P. L., Gow P. J. Progressive systemic sclerosis in Auckland: a ten year review with emphasis on prognostic features. Aust N Z J Med. 1981 Dec;11(6):657–662. doi: 10.1111/j.1445-5994.1981.tb03542.x. [DOI] [PubMed] [Google Scholar]
  24. Emerit I., Housset E., Feingold J. Chromosomal breakage and scleroderma: studies in family members. J Lab Clin Med. 1976 Jul;88(1):81–86. [PubMed] [Google Scholar]
  25. FARMER R. G., GIFFORD R. W., Jr, HINES E. A., Jr Prognostic significance of Raynaud's phenomenon and other clinical characteristics of systemic scleroderma. A study of 271 cases. Circulation. 1960 Jun;21:1088–1095. doi: 10.1161/01.cir.21.6.1088. [DOI] [PubMed] [Google Scholar]
  26. Finch W. R., Rodnan G. P., Buckingham R. B., Prince R. K., Winkelstein A. Bleomycin-induced scleroderma. J Rheumatol. 1980 Sep-Oct;7(5):651–659. [PubMed] [Google Scholar]
  27. Freni-Titulaer L. W., Kelley D. B., Grow A. G., McKinley T. W., Arnett F. C., Hochberg M. C. Connective tissue disease in southeastern Georgia: a case-control study of etiologic factors. Am J Epidemiol. 1989 Aug;130(2):404–409. doi: 10.1093/oxfordjournals.aje.a115348. [DOI] [PubMed] [Google Scholar]
  28. Genth E., Mierau R., Genetzky P., von Mühlen C. A., Kaufmann S., von Wilmowsky H., Meurer M., Krieg T., Pollmann H. J., Hartl P. W. Immunogenetic associations of scleroderma-related antinuclear antibodies. Arthritis Rheum. 1990 May;33(5):657–665. doi: 10.1002/art.1780330508. [DOI] [PubMed] [Google Scholar]
  29. Giordano M., Valentini G., Lupoli S., Giordano A. Pregnancy and systemic sclerosis. Arthritis Rheum. 1985 Feb;28(2):237–238. doi: 10.1002/art.1780280227. [DOI] [PubMed] [Google Scholar]
  30. Giordano M., Valentini G., Migliaresi S., Picillo U., Vatti M. Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. J Rheumatol. 1986 Oct;13(5):911–916. [PubMed] [Google Scholar]
  31. Gladman D. D., Keystone E. C., Baron M., Lee P., Cane D., Mervert H. Increased frequency of HLA-DR5 in scleroderma. Arthritis Rheum. 1981 Jun;24(6):854–856. doi: 10.1002/art.1780240614. [DOI] [PubMed] [Google Scholar]
  32. Greger R. E., Greger R. E. Familial progressive systemic scleroderma. Arch Dermatol. 1975 Jan;111(1):81–85. [PubMed] [Google Scholar]
  33. Guseva N. G., Folomeeva O. M., Oskilko T. G. Semeinaia sistemnaia sklerodermiia: nabliudenie konkordantnykh monoziogotnykh bliznetsov. Ter Arkh. 1981;53(7):43–47. [PubMed] [Google Scholar]
  34. Haustein U. F., Ziegler V. Environmentally induced systemic sclerosis-like disorders. Int J Dermatol. 1985 Apr;24(3):147–151. doi: 10.1111/j.1365-4362.1985.tb05745.x. [DOI] [PubMed] [Google Scholar]
  35. Hughes P., Gelsthorpe K., Doughty R. W., Rowell N. R., Rosenthal F. D., Sneddon I. B. The association of HLA-B8 with visceral disease in systemic sclerosis. Clin Exp Immunol. 1978 Mar;31(3):351–356. [PMC free article] [PubMed] [Google Scholar]
  36. Janssens X., Herman L., Mielants H., Verbruggen G., Veys E. M. Disease manifestations of progressive systemic sclerosis: sensitivity and specificity. Clin Rheumatol. 1987 Dec;6(4):532–538. doi: 10.1007/BF02330590. [DOI] [PubMed] [Google Scholar]
  37. Kallenberg C. G., Van der Voort-Beelen J. M., D'Amaro J., The T. H. Increased frequency of B8/DR3 in scleroderma and association of the haplotype with impaired cellular immune response. Clin Exp Immunol. 1981 Mar;43(3):478–485. [PMC free article] [PubMed] [Google Scholar]
  38. Kilbourne E. M., Rigau-Perez J. G., Heath C. W., Jr, Zack M. M., Falk H., Martin-Marcos M., de Carlos A. Clinical epidemiology of toxic-oil syndrome. Manifestations of a New Illness. N Engl J Med. 1983 Dec 8;309(23):1408–1414. doi: 10.1056/NEJM198312083092302. [DOI] [PubMed] [Google Scholar]
  39. Kumagai Y., Shiokawa Y., Medsger T. A., Jr, Rodnan G. P. Clinical spectrum of connective tissue disease after cosmetic surgery. Observations on eighteen patients and a review of the Japanese literature. Arthritis Rheum. 1984 Jan;27(1):1–12. doi: 10.1002/art.1780270101. [DOI] [PubMed] [Google Scholar]
  40. Kurland L. T., Hauser W. A., Ferguson R. H., Holley K. E. Epidemiologic features of diffuse connective tissue disorders in Rochester, Minn., 1951 through 1967, with special reference to systemic lupus erythematosus. Mayo Clin Proc. 1969 Sep;44(9):649–663. [PubMed] [Google Scholar]
  41. Lee P., Alderdice C., Wilkinson S., Keystone E. C., Urowitz M. B., Gladman D. D. Malignancy in progressive systemic sclerosis--association with breast carcinoma. J Rheumatol. 1983 Aug;10(4):665–666. [PubMed] [Google Scholar]
  42. Livingston J. Z., Scott T. E., Wigley F. M., Anhalt G. J., Bias W. B., McLean R. H., Hochberg M. C. Systemic sclerosis (scleroderma): clinical, genetic, and serologic subsets. J Rheumatol. 1987 Jun;14(3):512–518. [PubMed] [Google Scholar]
  43. Lockey J. E., Kelly C. R., Cannon G. W., Colby T. V., Aldrich V., Livingston G. K. Progressive systemic sclerosis associated with exposure to trichloroethylene. J Occup Med. 1987 Jun;29(6):493–496. [PubMed] [Google Scholar]
  44. Lynch C. J., Singh G., Whiteside T. L., Rodnan G. P., Medsger T. A., Jr, Rabin B. S. Histocompatibility antigens in progressive systemic sclerosis (PSS; scleroderma). J Clin Immunol. 1982 Oct;2(4):314–318. doi: 10.1007/BF00915073. [DOI] [PubMed] [Google Scholar]
  45. Maddison P. J., Skinner R. P., Pereira R. S., Black C. M., Ansell B. M., Jayson M. I., Rowell N. R., Welsh K. I. Antinuclear antibodies in the relatives and spouses of patients with systemic sclerosis. Ann Rheum Dis. 1986 Oct;45(10):793–799. doi: 10.1136/ard.45.10.793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Maricq H. R., Weinrich M. C., Keil J. E., LeRoy E. C. Prevalence of Raynaud phenomenon in the general population. A preliminary study by questionnaire. J Chronic Dis. 1986;39(6):423–427. doi: 10.1016/0021-9681(86)90109-8. [DOI] [PubMed] [Google Scholar]
  47. Masi A. T., D'Angelo W. A. Epidemiology of fatal systemic sclerosis (diffuse scleroderma). A 15-year survey in Baltimore. Ann Intern Med. 1967 May;66(5):870–883. doi: 10.7326/0003-4819-66-5-870. [DOI] [PubMed] [Google Scholar]
  48. McGregor A. R., Watson A., Yunis E., Pandey J. P., Takehara K., Tidwell J. T., Ruggieri A., Silver R. M., LeRoy E. C., Maricq H. R. Familial clustering of scleroderma spectrum disease. Am J Med. 1988 Jun;84(6):1023–1032. doi: 10.1016/0002-9343(88)90307-5. [DOI] [PubMed] [Google Scholar]
  49. McHugh N. J., Reilly P. A., McHugh L. A. Pregnancy outcome and autoantibodies in connective tissue disease. J Rheumatol. 1989 Jan;16(1):42–46. [PubMed] [Google Scholar]
  50. Medsger T. A., Jr, Masi A. T. Epidemiology of systemic sclerosis (scleroderma). Ann Intern Med. 1971 May;74(5):714–721. doi: 10.7326/0003-4819-74-5-714. [DOI] [PubMed] [Google Scholar]
  51. Medsger T. A., Jr, Masi A. T., Rodnan G. P., Benedek T. G., Robinson H. Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients. Ann Intern Med. 1971 Sep;75(3):369–376. doi: 10.7326/0003-4819-75-3-369. [DOI] [PubMed] [Google Scholar]
  52. Medsger T. A., Jr, Masi A. T. Survival with scleroderma. II. A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients. J Chronic Dis. 1973 Oct;26(10):647–660. doi: 10.1016/0021-9681(73)90054-4. [DOI] [PubMed] [Google Scholar]
  53. Medsger T. A., Jr, Masi A. T. The epidemiology of systemic sclerosis (scleroderma) among male U.S. veterans. J Chronic Dis. 1978 Feb;31(2):73–85. doi: 10.1016/0021-9681(78)90092-9. [DOI] [PubMed] [Google Scholar]
  54. Michet C. J., Jr, McKenna C. H., Elveback L. R., Kaslow R. A., Kurland L. T. Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc. 1985 Feb;60(2):105–113. doi: 10.1016/s0025-6196(12)60294-8. [DOI] [PubMed] [Google Scholar]
  55. Mollenhauer E., Schmidt R., Heinrichs M., Rittner C. Scleroderma: possible significance of silent alleles at the C4B locus. Arthritis Rheum. 1984 Jun;27(6):711–712. doi: 10.1002/art.1780270619. [DOI] [PubMed] [Google Scholar]
  56. Mund D. J., Greenwald R. A. The CREST syndrome variant of scleroderma in a mother-daughter pair. J Rheumatol. 1978 Fall;5(3):307–310. [PubMed] [Google Scholar]
  57. ORABONA M. L., ALBANO O. Progressive systemic sclerosis (or visceral scleroderma); review of literature and report of cases. Acta Med Scand Suppl. 1958;333:1–170. [PubMed] [Google Scholar]
  58. Owens G. R., Medsger T. A. Systemic sclerosis secondary to occupational exposure. Am J Med. 1988 Jul;85(1):114–116. doi: 10.1016/0002-9343(88)90515-3. [DOI] [PubMed] [Google Scholar]
  59. Palestine R. F., Millns J. L., Spigel G. T., Schroeter A. L. Skin manifestations of pentazocine abuse. J Am Acad Dermatol. 1980 Jan;2(1):47–55. doi: 10.1016/s0190-9622(80)80292-1. [DOI] [PubMed] [Google Scholar]
  60. Pereira S., Black C., Welsh K., Ansell B., Jayson M., Maddison P., Rowell N. Autoantibodies and immunogenetics in 30 patients with systemic sclerosis and their families. J Rheumatol. 1987 Aug;14(4):760–765. [PubMed] [Google Scholar]
  61. Peters-Golden M., Wise R. A., Hochberg M., Stevens M. B., Wigley F. M. Incidence of lung cancer in systemic sclerosis. J Rheumatol. 1985 Dec;12(6):1136–1139. [PubMed] [Google Scholar]
  62. Posada M., Castro M., Kilbourne E. M., Diaz de Rojas F., Abaitua I., Tabuenca J. M., Vioque A. Toxic-oil syndrome: case reports associated with the ITH oil refinery in Sevilla. Food Chem Toxicol. 1987 Jan;25(1):87–90. doi: 10.1016/0278-6915(87)90310-3. [DOI] [PubMed] [Google Scholar]
  63. REES R. B., BENNETT J. Localized scleroderma in father and daughter. AMA Arch Derm Syphilol. 1953 Sep;68(3):360–360. [PubMed] [Google Scholar]
  64. Rabin B. S., Rodnan G. P., Bassion S., Gill T. J., 3rd Letter: HL-A antigens in progressive systemic sclerosis (scleroderma). Arthritis Rheum. 1975 Jul-Aug;18(4):381–382. doi: 10.1002/art.1780180418. [DOI] [PubMed] [Google Scholar]
  65. Rendall J. R., McKenzie A. W. Familial scleroderma. Br J Dermatol. 1974 Nov;91(5):517–522. doi: 10.1111/j.1365-2133.1974.tb12939.x. [DOI] [PubMed] [Google Scholar]
  66. Rodnan G. P., Benedek T. G., Medsger T. A., Jr, Cammarata R. J. The association of progressive systemic sclerosis (scleroderma) with coal miners' pneumoconiosis and other forms of silicosis. Ann Intern Med. 1967 Feb;66(2):323–334. doi: 10.7326/0003-4819-66-2-323. [DOI] [PubMed] [Google Scholar]
  67. Roumm A. D., Medsger T. A., Jr Cancer and systemic sclerosis. An epidemiologic study. Arthritis Rheum. 1985 Dec;28(12):1336–1340. doi: 10.1002/art.1780281204. [DOI] [PubMed] [Google Scholar]
  68. Rowell N. R. The prognosis of systemic sclerosis. Br J Dermatol. 1976 Jul;95(1):57–60. doi: 10.1111/j.1365-2133.1976.tb15535.x. [DOI] [PubMed] [Google Scholar]
  69. Rush P. J., Chaiton A. Scleroderma, renal failure and death associated with exposure to urea formaldehyde foam insulation. J Rheumatol. 1986 Apr;13(2):475–476. [PubMed] [Google Scholar]
  70. Serup J., Hagdrup H. K. Age at menopause of females with systemic sclerosis. Acta Derm Venereol. 1983;63(1):71–73. [PubMed] [Google Scholar]
  71. Sheldon W. B., Lurie D. P., Maricq H. R., Kahaleh M. B., DeLustro F. A., Gibofsky A., LeRoy E. C. Three siblings with scleroderma (systemic sclerosis) and two with Raynaud's phenomenon from a single kindred. Arthritis Rheum. 1981 May;24(5):668–676. doi: 10.1002/art.1780240507. [DOI] [PubMed] [Google Scholar]
  72. Silman A. J., Black C. Increased incidence of spontaneous abortion and infertility in women with scleroderma before disease onset: a controlled study. Ann Rheum Dis. 1988 Jun;47(6):441–444. doi: 10.1136/ard.47.6.441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Silman A. J., Jones S. Pet ownership: a possible risk factor for scleroderma. Br J Rheumatol. 1990 Dec;29(6):494–494. doi: 10.1093/rheumatology/29.6.494. [DOI] [PubMed] [Google Scholar]
  74. Silman A. J. Mortality from scleroderma in England and Wales 1968-1985. Ann Rheum Dis. 1991 Feb;50(2):95–96. doi: 10.1136/ard.50.2.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Silman A., Jannini S., Symmons D., Bacon P. An epidemiological study of scleroderma in the West Midlands. Br J Rheumatol. 1988 Aug;27(4):286–290. doi: 10.1093/rheumatology/27.4.286. [DOI] [PubMed] [Google Scholar]
  76. Slate W. G., Graham A. R. Scleroderma and pregnancy. Am J Obstet Gynecol. 1968 Jun 1;101(3):335–341. doi: 10.1016/0002-9378(68)90059-8. [DOI] [PubMed] [Google Scholar]
  77. Somorin A. O., Mordi V. I. Connective tissue disease in Nigeria with emphasis on scleroderma. Cent Afr J Med. 1980 Mar;26(3):59–63. [PubMed] [Google Scholar]
  78. Soppi E., Lehtonen A., Toivanen A. Familial progressive systemic sclerosis (scleroderma): immunological analysis of two patients and six siblings from a single kindred. Clin Exp Immunol. 1982 Nov;50(2):275–282. [PMC free article] [PubMed] [Google Scholar]
  79. Sparrow G. P. A connective tissue disorder similar to vinyl chloride disease in a patient exposed to perchlorethylene. Clin Exp Dermatol. 1977 Mar;2(1):17–22. doi: 10.1111/j.1365-2230.1977.tb01532.x. [DOI] [PubMed] [Google Scholar]
  80. Steen V. D., Conte C., Day N., Ramsey-Goldman R., Medsger T. A., Jr Pregnancy in women with systemic sclerosis. Arthritis Rheum. 1989 Feb;32(2):151–157. doi: 10.1002/anr.1780320207. [DOI] [PubMed] [Google Scholar]
  81. Sternberg E. M., Van Woert M. H., Young S. N., Magnussen I., Baker H., Gauthier S., Osterland C. K. Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa. N Engl J Med. 1980 Oct 2;303(14):782–787. doi: 10.1056/NEJM198010023031403. [DOI] [PubMed] [Google Scholar]
  82. TUFFANELLI D. L., WINKELMANN R. K. Systemic scleroderma, A clinical study of 727 cases. Arch Dermatol. 1961 Sep;84:359–371. doi: 10.1001/archderm.1961.01580150005001. [DOI] [PubMed] [Google Scholar]
  83. Tabuenca J. M. Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline. Lancet. 1981 Sep 12;2(8246):567–568. doi: 10.1016/s0140-6736(81)90949-1. [DOI] [PubMed] [Google Scholar]
  84. Tan P. L., Wigley R. D., Borman G. B. Clinical criteria for systemic sclerosis. Arthritis Rheum. 1981 Dec;24(12):1589–1590. doi: 10.1002/art.1780241226. [DOI] [PubMed] [Google Scholar]
  85. Tomlinson I. W., Jayson M. I. Systemic sclerosis after therapy with appetite suppressants. J Rheumatol. 1984 Apr;11(2):254–254. [PubMed] [Google Scholar]
  86. Trozak D. J., Gould W. M. Cocaine abuse and connective tissue disease. J Am Acad Dermatol. 1984 Mar;10(3):525–525. doi: 10.1016/s0190-9622(84)80112-7. [DOI] [PubMed] [Google Scholar]
  87. Tuffanelli D. L. Scleroderma, immunological and genetic disease in three families. Dermatologica. 1969;138(2):93–104. doi: 10.1159/000253971. [DOI] [PubMed] [Google Scholar]
  88. Veltman G., Lange C. E., Jühe S., Stein G., Bachner U. Clinical manifestations and course of vinyl chloride disease. Ann N Y Acad Sci. 1975 Jan 31;246:6–17. doi: 10.1111/j.1749-6632.1975.tb51076.x. [DOI] [PubMed] [Google Scholar]
  89. WALDER G. SOLVENTS AND SCLERODERMA. Lancet. 1965 Aug 28;2(7409):436–437. doi: 10.1016/s0140-6736(65)90778-6. [DOI] [PubMed] [Google Scholar]
  90. Walder B. K. Do solvents cause scleroderma? Int J Dermatol. 1983 Apr;22(3):157–158. doi: 10.1111/j.1365-4362.1983.tb03354.x. [DOI] [PubMed] [Google Scholar]
  91. Whiteside T. L., Medsger T. A., Jr, Rodnan G. P. HLA-DR antigens in progressive systemic sclerosis (scleroderma). J Rheumatol. 1983 Feb;10(1):128–131. [PubMed] [Google Scholar]
  92. Wigley R., Borman B. Medical geography and the aetiology of the rare connective tissue diseases in New Zealand. Soc Sci Med Med Geogr. 1980 Jun;14(2):175–183. doi: 10.1016/0160-8002(80)90060-x. [DOI] [PubMed] [Google Scholar]
  93. Williams J. M., Downey C., Thonar E. J. Increase in levels of serum keratan sulfate following cartilage proteoglycan degradation in the rabbit knee joint. Arthritis Rheum. 1988 Apr;31(4):557–560. doi: 10.1002/art.1780310415. [DOI] [PubMed] [Google Scholar]
  94. Wynn J., Fineberg N., Matzer L., Cortada X., Armstrong W., Dillon J. C., Kinney E. L. Prediction of survival in progressive systemic sclerosis by multivariate analysis of clinical features. Am Heart J. 1985 Jul;110(1 Pt 1):123–127. doi: 10.1016/0002-8703(85)90525-3. [DOI] [PubMed] [Google Scholar]
  95. Yamakage A., Ishikawa H., Saito Y., Hattori A. Occupational scleroderma-like disorder occurring in men engaged in the polymerization of epoxy resins. Dermatologica. 1980;161(1):33–44. doi: 10.1159/000250328. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES